This paper explores the feasibility of using potassium manganate (K 2 MnO 4 ) in water treatment.
INTRODUCTION
The production of drinking water from natural waters requires the removal of numerous impurities including inorganic species, natural organic matter and anthropogenic micropollutants. Coagulants and oxidants are important water treatment chemicals with distinct roles in relation to the removal of impurities. Coagulants are used to destabilize and aggregate the colloidal impurities to a scale that they can be removed effectively by sedimentation, flotation and filtration. Pre-oxidation can also remove both organic and inorganic contaminants either directly, by oxidative degradation, or indirectly by enhancing the subsequent coagulation performance. In view of current trends of deteriorating raw water quality and more stringent standards of drinking water quality, more efficient and economical chemical reagents need to be developed and applied to meet these challenges. Of special interest are chemicals that can act as both oxidants and coagulants, such as permanganate (Mn(VII)) and ferrate (Fe(VI)) which have received much attention in recent years (Ma et 
METHODS OF USE OF K 2 MnO 4 IN WATER TREATMENT
In addition to final disinfection, the usual points of chemical oxidant dosing are pre-oxidation and intermediate oxidation.
Generally, pre-oxidation is employed to enhance the coagu- (ii) Pre-mixing of the K 2 MnO 4 into water prior to addition to the bulk water. In this case, the manganate will disproportionate to MnO 4 À and MnO 2 in the pre-mixing, and subsequent treatment of the bulk water will involve oxidation and coagulation/adsorption by these species.
(iii) Pre-mixing with a selected reducing agent to produce solid phase MnO 2 which can be applied to the bulk water as a combined oxidant, adsorbent and coagulant.
Our current research studies are evaluating the performance and relative advantages of these three modes of applying K 2 MnO 4 in water treatment. where the performance at a dose of 12.50 mg/L was found to be inferior to that at 11.08 mg/L (Figure 3) . At a FeMnO dose of 11.08 mg/L the best coagulation performance was observed at pH 7 in terms of producing the highest FI value (1.6) in the shortest flocculation time (∼300 s). In general, the conditions giving greater coagulation performance, as indicated by the FI values, corresponded to those achieving a low residual turbidity after settling. The results given in Figures 5-7 show that the minimum FeMnO dosages to achieve a residual turbidity below 5.0 NTU were 6.52, 5.61
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and 11.08 mg/L, for the three pH values, respectively. To achieve an overall practical economy, since the chemical dosage is directly related to the cost of water treatment, the dosages of FeMnO required to achieve low residual turbidities can be taken to be the optimum, rather than those producing the greatest FI values. Thus, the optimum dosages for FeMnO for each pH condition are those summarized in Table 2 .
The results of experiments with HA model water are given in Figures 4 (FI response) and 8 (residual NPDOC).
In these experiments (at pH 5) the onset of flocculation occurred rapidly and a very short time (∼240 s) was needed to attain the maximum FI value, except at the minimum FeMnO dose of 4.78 mg/L where no FI response was evident. An optimal dose of 9.56 mg/L was suggested from the maximum FI values and the residual NPDOC sulphate can achieve a high degree of coagulation and particulate solids removal. It is expected that the industrial production cost of K 2 MnO 4 will be significantly less than currently for KMnO 4 , which will make its cost-effectiveness favourable for use in the full-scale treatment of water.
Further studies need to be conducted with manganate to evaluate more fully its treatment performance, methods of application, cost of production and the presence of residual manganese in treated water. Overall, it is believed that K 2 MnO 4 has the potential to be a valuable water treatment chemical in the future.
